First of Its Kind SARS-CoV-2 Antibody Test Enables Personalized COVID-19 Assessments
The COVID-19 pandemic remains a healthcare concern as new strains of the virus have emerged. Now, a new test using best-in-class technology offers each patient a personalized status of his or her protection against COVID-19, making it an important new tool in the enduring fight against the pandemic. More...15 Apr 2022
Rapid, Saliva-Based and Ultra-Sensitive SARS-CoV-2 Screening System Returns Result With 98% Accuracy
A pilot project has validated the feasibility of a rapid, highly sensitive population screening platform for detecting viruses such as those causing COVID-19. The technology makes repeated testing quicker and easier without compromising quality. More...15 Apr 2022
New Type of COVID-19 Test Offers Advantages over Lateral Flow Tests
Rapid antigen tests can quickly and conveniently tell a person that they are positive for Covid-19. However, because the antibody-based tests aren’t very sensitive, they can fail to detect early infections with low viral loads. Now, a team of researchers has developed a rapid test that relies on molecularly imprinted polymer nanoparticles, rather than antibodies, for detection. More...14 Apr 2022
30-Second Coronavirus Test Returns Results as Accurately and Sensitively as PCR Test
Researchers have now developed a COVID-19 testing device that can detect coronavirus infection in as little as 30 seconds as sensitively and accurately as a PCR, or polymerase chain reaction test, the gold standard of testing. More...08 Apr 2022
Testing for Proteins in Saliva Could Help Detect COVID-19 and Predict Severity
Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with COVID-19. The proteins, known as ephrin ligands, could potentially serve as a biomarker to help doctors identify patients who are at risk for serious illness. More...07 Apr 2022
In Other News
Seegene's Syndromic Test Detects 21 Targets for 19 Respiratory Viruses in Single Sample, Including COVID-19 and Flu
Blood Test Identifies Stillbirth, Placentitis in Women with COVID-19
First-of-Its-Kind Antibody Test Measures Degree of Immunity from COVID-19
Easier, Faster Assay Enables Many More Laboratories to Identify COVID-19 Variants
Saliva-Based ELISA Tests Measure COVID Neutralizing Antibodies in Multiple Samples at Same Time
Sensor for Faster, More Accurate COVID-19 Tests Could Revolutionize Virus Testing
Saliva Testing for COVID-19 Quicker, Safer than Nasal Swabs
Ground-Breaking and Novel Assays to Help Assess Organ and Tissue Damage in Transplant and COVID-19 Patients
New Rapid COVID-19 Test to Improve Response to Future Outbreaks
Urinary Proteome Analysis Predicts Transition from Moderate to Severe Disease in COVID-19 Progression
New COVID-19 PCR Test Identifies All SARS-CoV-2 Variants in Positive Patient Sample
Blood Test May Identify Higher Risk Pregnancies in Women Diagnosed with COVID-19
Proline-Specific Peptidase Activities in Plasma of Hospitalized COVID-19 Patients
Next-Gen Graphene Biosensor Technology Enables Lab Quality Diagnostics of Infectious Diseases, Anytime, Anywhere
FTIR-Based Saliva Test Detects Body’s Response to COVID-19
Thermo Fisher Introduces Low-Cost RT-LAMP Tests to Simplify Infectious Disease Surveillance
Low-Cost Multiplexed Electrochemical Biomarker Detection Platform to Be Commercialized in POC Diagnostics
First and Only Fully Integrated Molecular Diagnostic Test Provides Lab-Quality Results in 15 Minutes
Seegene Unveils New Assay Optimized for On-Site Testing in 'Living with COVID-19' Era
Seegene Signs Contract to Deliver Shipment of Four Million Allplex SARS-CoV-2/FluA/FluB/RSV Assay to Brazil
Robotic VR System to Teleoperate Robots for Performing COVID-19 Swab Tests
New Low-Cost Transistor Quantifies SARS-CoV-2 Neutralizing Antibodies in Blood
Portable Instrument Combines Fluorescence Reader and Microfluidic Chip for Detection of SARS-CoV-2 in Saliva